399 related articles for article (PubMed ID: 31228798)
1. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats.
Lian FZ; Cheng P; Ruan CS; Ling XX; Wang XY; Pan M; Chen ML; Shen AZ; Gao S
Biomed Pharmacother; 2019 Sep; 117():109124. PubMed ID: 31228798
[TBL] [Abstract][Full Text] [Related]
2. Effects of Xin-Ji-Er-Kang on heart failure induced by myocardial infarction: Role of inflammation, oxidative stress and endothelial dysfunction.
Hu J; Cheng P; Huang GY; Cai GW; Lian FZ; Wang XY; Gao S
Phytomedicine; 2018 Mar; 42():245-257. PubMed ID: 29655692
[TBL] [Abstract][Full Text] [Related]
3. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
4. Xin-Ji-Er-Kang Alleviates Myocardial Infarction-Induced Cardiovascular Remodeling in Rats by Inhibiting Endothelial Dysfunction.
Cheng P; Lian FZ; Wang XY; Cai GW; Huang GY; Chen ML; Shen AZ; Gao S
Biomed Res Int; 2019; 2019():4794082. PubMed ID: 31341899
[TBL] [Abstract][Full Text] [Related]
5. Xin-Ji-Er-Kang protects myocardial and renal injury in hypertensive heart failure in mice.
Ling XX; Chen H; Fu BB; Ruan CS; Pana M; Zhou K; Fang ZR; Shao JT; Zhu FQ; Gao S
Phytomedicine; 2021 Oct; 91():153675. PubMed ID: 34332285
[TBL] [Abstract][Full Text] [Related]
6. Effects of traditional Chinese medicine Xin-Ji-Er-Kang formula on 2K1C hypertensive rats: role of oxidative stress and endothelial dysfunction.
Yu TT; Guo K; Chen HC; Lan CZ; Wang J; Huang LL; Wang XH; Zhang Z; Gao S
BMC Complement Altern Med; 2013 Jul; 13():173. PubMed ID: 23849603
[TBL] [Abstract][Full Text] [Related]
7. Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats.
Huang LL; Pan C; Yu TT; Guo K; Wang XH; Zhang JY; Wang HZ; Gao S
Afr J Tradit Complement Altern Med; 2014; 11(5):16-27. PubMed ID: 25395699
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Xin-Ji-Er-Kang on cardiovascular remodeling in high-salt induced hypertensive mice: Role ofoxidative stress and endothelial dysfunction.
Wang XY; Huang GY; Lian FZ; Pan M; Ruan CS; Ling XX; Chen ML; Shen AZ; Gao S
Biomed Pharmacother; 2019 Jul; 115():108937. PubMed ID: 31078040
[TBL] [Abstract][Full Text] [Related]
9. Xin-Ji-Er-Kang Alleviates Isoproterenol-Induced Myocardial Hypertrophy in Mice through the Nrf2/HO-1 Signaling Pathway.
Yu TT; Sun LJ; Chen C; Wang ZJ; Liu XS; Zhu FQ; Gao S
Evid Based Complement Alternat Med; 2022; 2022():7229080. PubMed ID: 36045660
[TBL] [Abstract][Full Text] [Related]
10. Ulinastatin protects rats with myocardial infarction by activating Nrf2/NOS pathway.
Wang S; Cheng ZY; Chen XJ; Xue HZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8990-8998. PubMed ID: 30575944
[TBL] [Abstract][Full Text] [Related]
11. Effects of Xinjierkang on Nrf2/HO-1 expression in viral myocarditis mice models.
Yin J; Li W; Yao W
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):137-141. PubMed ID: 33040827
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of polysaccharide extract from Xin-Ji-Er-Kang formula on Ang II-induced HUVECs injury, L-NAME-induced hypertension and cardiovascular remodeling in mice.
Ding L; Cheng P; Wang L; Hu J; Zhang YX; Cai GW; Huang GY; Gao S
BMC Complement Altern Med; 2019 Jun; 19(1):127. PubMed ID: 31196042
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of Xinji'erkang on myocardial infarction induced cardiac injury in mice.
Hu J; Zhang YX; Wang L; Ding L; Huang GY; Cai GW; Gao S
BMC Complement Altern Med; 2017 Jun; 17(1):338. PubMed ID: 28651598
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of total flavonoids from Clinopodium chinense (Benth.) O. Ktze on myocardial injury in vivo and in vitro via regulation of Akt/Nrf2/HO-1 pathway.
Zhang HJ; Chen RC; Sun GB; Yang LP; Zhu YD; Xu XD; Sun XB
Phytomedicine; 2018 Feb; 40():88-97. PubMed ID: 29496179
[TBL] [Abstract][Full Text] [Related]
16. Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2/HO-1 signaling pathway.
Jin W; Zhu X; Yao F; Xu X; Chen X; Luo Z; Zhao D; Li X; Leng X; Sun L
Biomed Pharmacother; 2020 Jan; 121():109676. PubMed ID: 31810119
[TBL] [Abstract][Full Text] [Related]
17. Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.
Chen X; Wan W; Guo Y; Ye T; Fo Y; Sun Y; Qu C; Yang B; Zhang C
Mol Med; 2021 Sep; 27(1):100. PubMed ID: 34488618
[TBL] [Abstract][Full Text] [Related]
18. DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-kB signaling pathway.
Zhao K; Wen LB
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8924-8931. PubMed ID: 30575936
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
Ibarra-Lara L; Sánchez-Aguilar M; Sánchez-Mendoza A; Del Valle-Mondragón L; Soria-Castro E; Carreón-Torres E; Díaz-Díaz E; Vázquez-Meza H; Guarner-Lans V; Rubio-Ruiz ME
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036029
[TBL] [Abstract][Full Text] [Related]
20. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
